Commonwealth Equity Services Portfolio holdings
AUM
$75.7B
1-Year Return
17%
This Quarter Return
+1.69%
1 Year Return
+17%
3 Year Return
+64.32%
5 Year Return
+107.58%
10 Year Return
+207.41%
AUM
$68.4B
AUM Growth
+$2.43B
(+3.7%)
Cap. Flow
+$2.13B
Cap. Flow
% of AUM
3.12%
Top 10 Holdings %
Top 10 Hldgs %
19.98%
Holding
4,281
New
226
Increased
2,094
Reduced
1,680
Closed
194
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$51M |
| 2 |
Fidelity Enhanced Large Cap Core ETF
FELC
|
$43M |
| 3 |
Microsoft
MSFT
|
$41.5M |
| 4 |
iShares Core Dividend Growth ETF
DGRO
|
$41.3M |
| 5 |
FT Vest Fund of Buffer ETFs
BUFR
|
$36.1M |
Top Sells
| 1 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
$31.5M |
| 2 |
iShares ESG Aware MSCI USA ETF
ESGU
|
$29.4M |
| 3 |
Vanguard Long-Term Bond ETF
BLV
|
$22.7M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$21.4M |
| 5 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
$18.1M |
Sector Composition
| 1 | Technology | 12.95% |
| 2 | Financials | 5.41% |
| 3 | Consumer Discretionary | 4.35% |
| 4 | Healthcare | 3.33% |
| 5 | Industrials | 3.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TGB
4026
Taseko Mines
TGB
$1.08B
| $24K | ﹤0.01% |
12,614
+395
| +3% | +$752 |
|
|
UBX
4027
DELISTED
Unity Biotechnology
UBX
| $24K | ﹤0.01% |
24,232
+120
| +0.5% | +$119 |
|
4028
Reviva Pharmaceuticals
RVPH
$30M
| $23K | ﹤0.01% |
12,892
+550
| +4% | +$981 |
|
4029
GrowGeneration
GRWG
$91.5M
| $22K | ﹤0.01% |
13,173
-16,550
| -56% | -$27.6K |
|
|
LGVN
4030
Longeveron
LGVN
$15.8M
| $22K | ﹤0.01% |
+12,455
| New | +$22K |
|
4031
Microvision
MVIS
$340M
| $22K | ﹤0.01% |
16,527
| – | – |
|
4032
Ocean Power Technologies
OPTT
$93.9M
| $21K | ﹤0.01% |
20,400
-3,000
| -13% | -$3.09K |
|
|
ZOM
4033
DELISTED
Zomedica Corp.
ZOM
| $21K | ﹤0.01% |
178,285
-125
| -0.1% | -$15 |
|
4034
NeuroSense Therapeutics
NRSN
$27.5M
| $20K | ﹤0.01% |
16,250
+3,625
| +29% | +$4.46K |
|
4035
W&T Offshore
WTI
$268M
| $20K | ﹤0.01% |
11,995
-1,786
| -13% | -$2.98K |
|
4036
BioSig Technologies, Inc. Common Stock
BSGM
$161M
| $19K | ﹤0.01% |
+12,520
| New | +$19K |
|
4037
Equillium
EQ
$108M
| $19K | ﹤0.01% |
25,000
| – | – |
|
4038
X4 Pharmaceuticals
XFOR
$80.8M
| $19K | ﹤0.01% |
842
| – | – |
|
4039
Beneficient
BENF
$3.41M
| $18K | ﹤0.01% |
24,149
+10,000
| +71% | +$7.45K |
|
|
CIF
4040
MFS Intermediate High Income Fund
CIF
$31.5M
| $18K | ﹤0.01% |
10,185
-914
| -8% | -$1.62K |
|
|
RGLS
4041
DELISTED
Regulus Therapeutics
RGLS
| $18K | ﹤0.01% |
11,700
+200
| +2% | +$308 |
|
4042
MIRA Pharmaceuticals
MIRA
$26.7M
| $17K | ﹤0.01% |
+15,072
| New | +$17K |
|
|
NB
4043
NioCorp Developments
NB
$334M
| $16K | ﹤0.01% |
10,174
| – | – |
|
4044
Karyopharm Therapeutics
KPTI
$58.2M
| $15K | ﹤0.01% |
1,486
+6
| +0.4% | +$61 |
|
4045
SKYX Platforms
SKYX
$128M
| $15K | ﹤0.01% |
+12,585
| New | +$15K |
|
4046
GEE Group
JOB
$21M
| $14K | ﹤0.01% |
66,200
| – | – |
|
|
OTLY
4047
Oatly Group
OTLY
$522M
| $14K | ﹤0.01% |
1,075
-516
| -32% | -$6.72K |
|
4048
Rani Therapeutics
RANI
$22.8M
| $14K | ﹤0.01% |
+10,409
| New | +$14K |
|
4049
BioAtla
BCAB
$29.7M
| $13K | ﹤0.01% |
21,800
| – | – |
|
4050
fuboTV
FUBO
$1.3B
| $13K | ﹤0.01% |
+10,407
| New | +$13K |
|